273 related articles for article (PubMed ID: 11224753)
21. Gadolinium Retention, Brain T1 Hyperintensity, and Endogenous Metals: A Comparative Study of Macrocyclic Versus Linear Gadolinium Chelates in Renally Sensitized Rats.
Rasschaert M; Emerit A; Fretellier N; Factor C; Robert P; Idée JM; Corot C
Invest Radiol; 2018 Jun; 53(6):328-337. PubMed ID: 29329151
[TBL] [Abstract][Full Text] [Related]
22. Nephrogenic systemic fibrosis: change in incidence following a switch in gadolinium agents and adoption of a gadolinium policy--report from two U.S. universities.
Altun E; Martin DR; Wertman R; Lugo-Somolinos A; Fuller ER; Semelka RC
Radiology; 2009 Dec; 253(3):689-96. PubMed ID: 19789233
[TBL] [Abstract][Full Text] [Related]
23. High Signal Intensity in Globus Pallidus and Dentate Nucleus on Unenhanced T1-weighted MR Images: Evaluation of Two Linear Gadolinium-based Contrast Agents.
Ramalho J; Castillo M; AlObaidy M; Nunes RH; Ramalho M; Dale BM; Semelka RC
Radiology; 2015 Sep; 276(3):836-44. PubMed ID: 26079490
[TBL] [Abstract][Full Text] [Related]
24. Multicenter, intra-individual comparison of single dose gadobenate dimeglumine and double dose gadopentetate dimeglumine for MR angiography of the peripheral arteries (the Peripheral VALUE Study).
Wang J; Yan F; Liu J; Lu J; Li D; Luan J; Wang X; Li Y; Iezzi R; De Cobelli F
J Magn Reson Imaging; 2013 Oct; 38(4):926-37. PubMed ID: 23371919
[TBL] [Abstract][Full Text] [Related]
25. Contrast-enhanced MR Angiography of the renal arteries: blinded multicenter crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine.
Prokop M; Schneider G; Vanzulli A; Goyen M; Ruehm SG; Douek P; Daprà M; Pirovano G; Kirchin MA; Spinazzi A
Radiology; 2005 Feb; 234(2):399-408. PubMed ID: 15616119
[TBL] [Abstract][Full Text] [Related]
26. Low-dose contrast-enhanced magnetic resonance imaging of brain metastases at 3.0 T using high-relaxivity contrast agents.
Huang B; Liang CH; Liu HJ; Wang GY; Zhang SX
Acta Radiol; 2010 Feb; 51(1):78-84. PubMed ID: 19912078
[TBL] [Abstract][Full Text] [Related]
27. The Benefits of High Relaxivity for Brain Tumor Imaging: Results of a Multicenter Intraindividual Crossover Comparison of Gadobenate Dimeglumine with Gadoterate Meglumine (The BENEFIT Study).
Vaneckova M; Herman M; Smith MP; Mechl M; Maravilla KR; Weichet J; Spampinato MV; Žižka J; Wippold FJ; Baima JJ; Babbel R; Bültmann E; Huang RY; Buhk JH; Bonafé A; Colosimo C; Lui S; Kirchin MA; Shen N; Pirovano G; Spinazzi A
AJNR Am J Neuroradiol; 2015 Sep; 36(9):1589-98. PubMed ID: 26185325
[TBL] [Abstract][Full Text] [Related]
28. Gadodiamide injection and gadopentetate dimeglumine. A double-blind study in MR imaging of the CNS.
Myhr G; Rinck PA; Børseth A
Acta Radiol; 1992 Sep; 33(5):405-9. PubMed ID: 1389644
[TBL] [Abstract][Full Text] [Related]
29. Multicenter, double-blind, randomized, intraindividual crossover comparison of gadobenate dimeglumine and gadopentetate dimeglumine for Breast MR imaging (DETECT Trial).
Martincich L; Faivre-Pierret M; Zechmann CM; Corcione S; van den Bosch HC; Peng WJ; Petrillo A; Siegmann KC; Heverhagen JT; Panizza P; Gehl HB; Diekmann F; Pediconi F; Ma L; Gilbert FJ; Sardanelli F; Belli P; Salvatore M; Kreitner KF; Weiss CM; Zuiani C
Radiology; 2011 Feb; 258(2):396-408. PubMed ID: 21163915
[TBL] [Abstract][Full Text] [Related]
30. Breast lesion detection and characterization with contrast-enhanced magnetic resonance imaging: Prospective randomized intraindividual comparison of gadoterate meglumine (0.15 mmol/kg) and gadobenate dimeglumine (0.075 mmol/kg) at 3T.
Clauser P; Helbich TH; Kapetas P; Pinker K; Bernathova M; Woitek R; Kaneider A; Baltzer PAT
J Magn Reson Imaging; 2019 Apr; 49(4):1157-1165. PubMed ID: 30552829
[TBL] [Abstract][Full Text] [Related]
31. Half-dose gadobenate dimeglumine versus standard-dose gadodiamide in dynamic magnetic resonance imaging of non-cirrhotic livers: a retrospective intra-individual crossover comparison.
Homayoon B; Diwakar H; Strovski E; Bakshi D; Harris AC; Thoeni RF; Chang SD
Abdom Imaging; 2014 Oct; 39(5):955-62. PubMed ID: 24676875
[TBL] [Abstract][Full Text] [Related]
32. Dose-Lowering in Contrast-Enhanced MRI of the Central Nervous System: A Retrospective, Parallel-Group Comparison Using Gadobenate Dimeglumine.
DeLano MC; Spampinato MV; Chang EY; Barr RG; Lichtenstein RJ; Colosimo C; Vymazal J; Wen Z; Lin DDM; Kirchin MA; Pirovano G
J Magn Reson Imaging; 2021 Nov; 54(5):1660-1675. PubMed ID: 34018290
[TBL] [Abstract][Full Text] [Related]
33. Comparison of gadobenate dimeglumine with gadopentetate dimeglumine for magnetic resonance imaging of liver tumors.
Kuwatsuru R; Kadoya M; Ohtomo K; Tanimoto A; Hirohashi S; Murakami T; Tanaka Y; Yoshikawa K; Katayama H
Invest Radiol; 2001 Nov; 36(11):632-41. PubMed ID: 11606840
[TBL] [Abstract][Full Text] [Related]
34. Incidence of immediate gadolinium contrast media reactions.
Prince MR; Zhang H; Zou Z; Staron RB; Brill PW
AJR Am J Roentgenol; 2011 Feb; 196(2):W138-43. PubMed ID: 21257854
[TBL] [Abstract][Full Text] [Related]
35. Low-dose gadobenate dimeglumine versus standard-dose gadopentate dimeglumine for delayed contrast-enhanced cardiac magnetic resonance imaging.
Balci NC; Inan N; Anik Y; Erturk MS; Ural D; Demirci A
Acad Radiol; 2006 Jul; 13(7):833-9. PubMed ID: 16777557
[TBL] [Abstract][Full Text] [Related]
36. Small Brain Lesion Enhancement and Gadolinium Deposition in the Rat Brain: Comparison Between Gadopiclenol and Gadobenate Dimeglumine.
Violas X; Rasschaert M; Santus R; Factor C; Corot C; Catoen S; Idée JM; Robert P
Invest Radiol; 2022 Feb; 57(2):130-139. PubMed ID: 34411032
[TBL] [Abstract][Full Text] [Related]
37. Less is better? Intraindividual and interindividual comparison between 0.075 mmol/kg of gadobenate dimeglumine and 0.1 mmol/kg of gadoterate meglumine for cranial MRI.
Khouri Chalouhi K; Papini GDE; Bandirali M; Sconfienza LM; Di Leo G; Sardanelli F
Eur J Radiol; 2014 Jul; 83(7):1245-1249. PubMed ID: 24816087
[TBL] [Abstract][Full Text] [Related]
38. Safety, tolerance, biodistribution, and MR imaging enhancement of the liver with gadobenate dimeglumine: results of clinical pharmacologic and pilot imaging studies in nonpatient and patient volunteers.
Spinazzi A; Lorusso V; Pirovano G; Kirchin M
Acad Radiol; 1999 May; 6(5):282-91. PubMed ID: 10228617
[TBL] [Abstract][Full Text] [Related]
39. Does higher gadolinium concentration play a role in the morphologic assessment of brain tumors? Results of a multicenter intraindividual crossover comparison of gadobutrol versus gadobenate dimeglumine (the MERIT Study).
Seidl Z; Vymazal J; Mechl M; Goyal M; Herman M; Colosimo C; Pasowicz M; Yeung R; Paraniak-Gieszczyk B; Yemen B; Anzalone N; Citterio A; Schneider G; Bastianello S; Ruscalleda J
AJNR Am J Neuroradiol; 2012 Jun; 33(6):1050-8. PubMed ID: 22383237
[TBL] [Abstract][Full Text] [Related]
40. Cytotoxicity of iodinated and gadolinium-based contrast agents in renal tubular cells at angiographic concentrations: in vitro study.
Heinrich MC; Kuhlmann MK; Kohlbacher S; Scheer M; Grgic A; Heckmann MB; Uder M
Radiology; 2007 Feb; 242(2):425-34. PubMed ID: 17179401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
